Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Dexamethasone × Endocrine × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 12 Lymphoid 11 Other hematologic neoplasm 8 Gastrointestinal 6 CNS 6 Genitourinary 4 Breast 4 Thoracic 3 Sarcoma 3 Myeloid 3 Gynecologic 3 Other 2 Head & Neck 2 Dermatologic 2 Tumor-Agnostic 1 Endocrine 1

Conditions

Pituitary Neoplasms 1 Pituitary Diseases 1

Interventions

Eating 5 Standard of Care 4 Radiofrequency Ablation 4 Endoscopic Mucosal Resection 3 lutetium Lu 177 dotatate 2 Yoga 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiosurgery 2 Proton Therapy 2 Propofol 2 Magnetic Resonance Imaging 2 Lutetium-177 2 Liquid Biopsy 2 Hydrocortisone 2 Exercise 2 Diet, Mediterranean 2 Diet 2 Desflurane 2 Data Collection 2 Control Groups 2 Calcium 2 Adrenalectomy 2 3-Iodobenzylguanidine 2 ziprasidone 1 pentetreotide 1 penpulimab 1 pegfilgrastim 1 parecoxib 1 loxoprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡